Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to 0.15%.

  • Molecular Partners Ag's Return on Capital Employed rose 2360394700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2360394700.0%. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Molecular Partners Ag's Return on Capital Employed stood at 0.15%, which was up 2360394700.0% from 0.13% recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Return on Capital Employed registered a high of 1720904.66% during Q3 2022, and its lowest value of 236039.31% during Q3 2024.
  • Its 5-year average for Return on Capital Employed is 121326.3%, with a median of 55.44% in 2025.
  • As far as peak fluctuations go, Molecular Partners Ag's Return on Capital Employed crashed by 2000000000bps in 2023, and later soared by 2000000000bps in 2025.
  • Over the past 5 years, Molecular Partners Ag's Return on Capital Employed (Quarter) stood at 710.16% in 2021, then crashed by -1421bps to 9378.66% in 2022, then soared by 111bps to 1019.58% in 2023, then crashed by -10770bps to 108789.98% in 2024, then surged by 100bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.13% for Q2 2025, and 111.01% during Q1 2025.